Taro-Palbociclib 75 mg

TARO-PALBOCICLIB 75 MG tablets are a pharmaceutical product used in cancer treatment. This medication is designed to target specific proteins involved in cell growth and division.

TARO-PALBOCICLIB 75 MG tablets are generally used in the treatment of certain types of cancer. Palbociclib is a type of CDK4/6 inhibitor, which works by slowing down the growth of cancer cells. This medication is often used in combination with other treatments to manage advanced or metastatic breast cancer in postmenopausal women.

Common effects of TARO-PALBOCICLIB 75 MG tablets may include fatigue, nausea, and low blood cell counts. Some individuals may also experience hair loss, diarrhea, or infections. It is important to discuss any persistent or severe side effects with a healthcare provider.

TARO-PALBOCICLIB 75 MG tablets should be handled with care. This medication can cause serious side effects, including low blood cell counts, which can increase the risk of infections and bleeding. Regular blood tests may be required to monitor for these effects. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks to the fetus.

TARO-PALBOCICLIB 75 MG tablets may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.